Substance / Medication

Chromium picolinate

Overview

Active Ingredient
chromium picolinate
RxNorm CUI
59308

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

555 trials linked to this intervention

555
Total Trials
58
Recruiting
150
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effects of dietary chromium picolinate supplementation on broiler growth performance: A meta-analysis.
Feng Chao, Wuren Qiqige, Zhang Xinyu et al. · PLoS One · 2021
PMID: 33822801Meta-AnalysisFull text (PMC)
Chromium picolinate supplementation for overweight or obese adults.
Tian Hongliang, Guo Xiaohu, Wang Xiyu et al. · Cochrane Database Syst Rev · 2013
PMID: 24293292Meta-AnalysisFull text (PMC)
Chromium picolinate for reducing body weight: meta-analysis of randomized trials.
Pittler M H, Stevinson C, Ernst E · Int J Obes Relat Metab Disord · 2003
PMID: 12664086Meta-Analysis
Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.
Kooshki Fateme, Moradi Fardin, Karimi Arash et al. · Eur J Gastroenterol Hepatol · 2021
PMID: 32804855RCT
Ilex paraguariensis, white mulberry and chromium picolinate in patients with pre-diabetes.
Derosa Giuseppe, D'Angelo Angela, Maffioli Pamela · Phytother Res · 2020
PMID: 31994278RCT
A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Overweight Individuals with Binge-Eating Disorder: Effects on Glucose Regulation.
Sala Margarita, Breithaupt Lauren, Bulik Cynthia M et al. · J Diet Suppl · 2017
PMID: 27835050RCT
Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial.
Ashoush Sherif, Abou-Gamrah Amgad, Bayoumy Hassan et al. · J Obstet Gynaecol Res · 2016
PMID: 26663540RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Chromium picolinate (substance)
SNOMED CT
442428005
UMLS CUI
C0163657
RxNorm CUI
59308

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
555
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.